Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lundgren

Showing results (481-490 of 681) with videos related to

Pageof 69
Sort By:
BMC Infectious Diseases|September 27, 2012
Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA studyDaria N Podlekareva, Joanne Reekie, Amanda Mocroft, et al.
HIV Medicine|July 23, 2013
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDAD Grint, L Peters, C Schwarze-Zander, et al.
Antiviral Therapy|June 25, 2008
Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological responseKoen Deforche, Alessandro Cozzi-Lepri, Kristof Theys, et al.
Antiviral Therapy|May 11, 2011
Haemoglobin and anaemia in the SMART studyAmanda Mocroft, Alan R Lifson, Giota Touloumi, et al.
Plos One|March 15, 2014
Factors associated with D-dimer levels in HIV-infected individualsAlvaro H Borges, Jemma L O'Connor, Andrew N Phillips, et al.
AIDS (London, England)|March 11, 2010
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruptionGregory J Dore, Vicente Soriano, Jürgen Rockstroh, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 12, 1998
Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study GroupM Burke, I Yust, C Katlama, et al.
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
The Journal of Infectious Diseases|February 6, 2013
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D studyLene Ryom, Amanda Mocroft, Ole Kirk, et al.
AIDS (London, England)|July 9, 2014
Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV diseaseÁlvaro H Borges, Jeffrey I Weitz, Gary Collins, et al.
Pageof 69

Showing results (481-490 of 681) with videos related to

Sort By:
Pageof 69
BMC Infectious Diseases|September 27, 2012
Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA studyDaria N Podlekareva, Joanne Reekie, Amanda Mocroft, et al.
HIV Medicine|July 23, 2013
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDAD Grint, L Peters, C Schwarze-Zander, et al.
Antiviral Therapy|June 25, 2008
Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological responseKoen Deforche, Alessandro Cozzi-Lepri, Kristof Theys, et al.
Antiviral Therapy|May 11, 2011
Haemoglobin and anaemia in the SMART studyAmanda Mocroft, Alan R Lifson, Giota Touloumi, et al.
Plos One|March 15, 2014
Factors associated with D-dimer levels in HIV-infected individualsAlvaro H Borges, Jemma L O'Connor, Andrew N Phillips, et al.
AIDS (London, England)|March 11, 2010
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruptionGregory J Dore, Vicente Soriano, Jürgen Rockstroh, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 12, 1998
Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study GroupM Burke, I Yust, C Katlama, et al.
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
The Journal of Infectious Diseases|February 6, 2013
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D studyLene Ryom, Amanda Mocroft, Ole Kirk, et al.
AIDS (London, England)|July 9, 2014
Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV diseaseÁlvaro H Borges, Jeffrey I Weitz, Gary Collins, et al.
Pageof 69